Sept 2 (Reuters) - Novartis AG NOVN.VX :
* Health Canada approves new indications for Promnitrope(R) (somatropin),
Canada's first subsequent entry biologic (biosimilar)
* Sandoz Canada inc - received approval from health Canada for a number of
additional indications for promnitrope
* Source text for Eikon ID:nGNXVEIZLa
* Further company coverage NOVN.VX